« Previous article
Rapid IgM/IgG Antibo...

9th February 2021  Product update: rapidvirology staff writer

COVID-19 Antigen Test Developed by Chinese Academy of Sciences is CE-Marked


The Ministry of Commerce in China has selected a new SARS-CoV-2 test kit developed by Shenzhen Zhongke Xianjian Medical Technology Co., Ltd. for export., 

The new antigen detection kit developed by Zhongke uses colloidal gold immunochromatography to qualitatively detect the nucleocapsid antigen of SARS-CoV-2 in human nasal or throat swab samples.

It can quickly detect positive cases when the viral load is high during the acute infection period, which can be used for early triage and rapid management of suspected populations.

As a professional aid for 2019 nCoV prediction, it is very suitable for large-scale screening in countries and regions where the epidemic is severe or spreading, and provides a powerful weapon for timely curbing the epidemic's development.

It can achieve rapid high-throughput screening of patients and suspected cases of new coronavirus pneumonia in hospitals, grassroots communities, outpatient clinics, schools, mobile monitoring points, stations, customs, government epidemic prevention centres and other places.

Product advantages 

  • Nano-gold particle enrichment technology: Using the exclusive research and development of ultra-nano gold particles to label monoclonal antibodies can significantly improve the detection sensitivity of colloidal gold. The detection sensitivity can be as high as 10pg/mL.

  • Simple sampling: Only a throat swab or nasal swab is required for sampling and testing

  • High accuracy: Compared with PCR results, >95% agreement.

  • Easy operation: No other equipment is needed, and results can be quickly produced within 15-20 minutes.

Zhongke Xianjian is a high-tech enterprise incubated by the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences.

This product has obtained CE-marking and national commercial export certification.


    

Tags:

Date Published: 9th February 2021

Source article link: View

Note: This content has been edited by a rapidvirology.com staff writer for style and content.


View full company details


Related news